Search

Search bills, members, committees and pages...

Sign In

AGIOS PHARMACEUTICALS

PreviousNext

8 federal lobbying filings, 2025 to 2026.

AGIOS PHARMACEUTICALS is a client on 8 federal lobbying filings, 2025 to 2026, reporting $10K across them. Pharmacy, Medicare/Medicaid, Health Issues Based in Massachusetts.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

2 it has hired, by filings.

RegistrantFilingsReported
AGIOS PHARMACEUTICALS6—
GRIDIRON PUBLIC AFFAIRS, LLC2$10K

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20264$10K$100K
20254—$50K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
HCRHealth Issues8
MMMMedicare/Medicaid6
MEDMedical/Disease Research/Clinical Labs4
PHAPharmacy2

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 5094Protect Patients from Costly Care Act1
H.R. 5187To establish in the Department of Defense a program to support the expansion of domestic bioindustrial manufa…1

Lobbyists

Named on the filings.

LobbyistClientsFilings
AARON KRUPP16
GREG CHESMORE12

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
AGIOS PHARMACEUTICALSAGIOS PHARMACEUTICALS2026 second_quarter$30KJul 20, 2026
AGIOS PHARMACEUTICALSGRIDIRON PUBLIC AFFAIRS, LLC2026 second_quarter$10KJul 17, 2026
AGIOS PHARMACEUTICALSGRIDIRON PUBLIC AFFAIRS, LLC2026 second_quarter—May 26, 2026
AGIOS PHARMACEUTICALSAGIOS PHARMACEUTICALS2026 first_quarter$70KApr 17, 2026
AGIOS PHARMACEUTICALSAGIOS PHARMACEUTICALS2025 fourth_quarter$20KJan 20, 2026
AGIOS PHARMACEUTICALSAGIOS PHARMACEUTICALS2025 third_quarter$10KOct 17, 2025
AGIOS PHARMACEUTICALSAGIOS PHARMACEUTICALS2025 second_quarter$20KJul 22, 2025
AGIOS PHARMACEUTICALSAGIOS PHARMACEUTICALS2025 second_quarter—Jun 12, 2025